We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.37B
1-Year Est. Return 71.68%
This Fund
S&P 500
This Quarter Est. Return
+23.86%
1 Year Est. Return
+71.68%
3 Year Est. Return
+198.05%
5 Year Est. Return
+324.32%
10 Year Est. Return
+2,686.25%
AUM
$1.37B
AUM Growth
+$61.8M
Cap. Flow
-$119M
Cap. Flow %
-8.67%
Top 10 Hldgs %
11.44%
Holding
1,623
New
447
Increased
343
Reduced
364
Closed
410

Top Buys

Rank Stock Value
1
JHG
Janus Henderson
JHG
+$11.4M
2
ROKU icon
Roku
ROKU
+$8.72M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$8.2M
4
ORCL icon
Oracle
ORCL
+$7.64M
5
NUVL
Nuvalent
NUVL
+$7.59M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$25.1M
2
STX icon
Seagate
STX
+$20.6M
3
CWAN
Clearwater Analytics
CWAN
+$14.7M
4
META icon
Meta Platforms (Facebook)
META
+$12.3M
5
ACLX
Arcellx
ACLX
+$11.3M

Sector Composition

Rank Sector Weight
1 Technology 19.02%
2 Healthcare 12.44%
3 Industrials 12.15%
4 Consumer Discretionary 11.47%
5 Financials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMCO icon
1276
Columbus McKinnon
CMCO
$465M
– –
-13,422
Closed -$195K
CMPX icon
1277
Compass Therapeutics
CMPX
$330M
– –
-18,000
Closed -$95.2K
CNM icon
1278
Core & Main
CNM
$7.9B
– –
-4,148
Closed -$205K
COGT icon
1279
Cogent Biosciences
COGT
$5.65B
– –
-64,222
Closed -$2.47M
COP icon
1280
ConocoPhillips
COP
$159B
– –
-5,495
Closed -$725K
CORN icon
1281
Teucrium Corn Fund
CORN
$153M
– –
-10,000
Closed -$184K
CORZ icon
1282
Core Scientific
CORZ
$5.42B
– –
-49,524
Closed -$741K
CR icon
1283
Crane Co
CR
$11.4B
– –
-1,658
Closed -$284K
CRBP icon
1284
Corbus Pharmaceuticals
CRBP
$140M
– –
-50,826
Closed -$477K
CRL icon
1285
Charles River Laboratories
CRL
$13.1B
– –
-1,204
Closed -$208K
CRTO icon
1286
Criteo S.A.
CRTO
$838M
– –
-79,515
Closed -$1.43M
CSGS
1287
DELISTED
CSG Systems International
CSGS
– –
-21,348
Closed -$1.71M
CTLP
1288
DELISTED
Cantaloupe
CTLP
– –
-100,301
Closed -$1.08M
CTMX icon
1289
CytomX Therapeutics
CTMX
$604M
– –
-121,912
Closed -$573K
CTRE icon
1290
CareTrust REIT
CTRE
$8.97B
– –
-16,037
Closed -$588K
CTRA
1291
DELISTED
Coterra Energy
CTRA
– –
-80,132
Closed -$2.82M
CUBE icon
1292
CubeSmart
CUBE
$8.94B
– –
-39,600
Closed -$1.45M
CURI icon
1293
CuriosityStream
CURI
$166M
– –
-11,055
Closed -$32.7K
CVGW
1294
DELISTED
Calavo Growers
CVGW
– –
-16,400
Closed -$423K
CVX icon
1295
Chevron
CVX
$415B
– –
-1,328
Closed -$275K
CWAN
1296
DELISTED
Clearwater Analytics
CWAN
– –
-623,487
Closed -$14.7M
CWB icon
1297
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.5B
– –
-19,940
Closed -$1.82M
CYTK icon
1298
Cytokinetics
CYTK
$9.65B
– –
-21,813
Closed -$1.44M
DAR icon
1299
Darling Ingredients
DAR
$10.3B
– –
-3,635
Closed -$225K
DAWN
1300
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-56,673
Closed -$1.22M
50 51
52
53 54

Similar funds

CA
CGN Advisors Manhattan, Kansas $1.37B AUM 15.64% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
WC
Whitney & Co Rochester, New York $1.37B AUM 32.12% 1-Year Est. Return
OCAI
O'Connor Alternative Investments New York $1.37B AUM
AIP
AE Industrial Partners Boca Raton, Florida $1.37B AUM 48.49% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
FCM
Fernbridge Capital Management Los Angeles, California $1.37B AUM 24.55% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return

Prelude Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Prelude Capital Management held 1,623 positions worth $1.37B, up 4.7% from $1.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Prelude Capital Management withdrew a net $119M in Q2 2026, closing 410 positions and reducing 364 holdings. Its most notable exit was Clearwater Analytics, an estimated $14.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Prelude Capital Management opened a new position in Vanguard S&P 500 ETF worth $8.44M.

  • Prelude Capital Management's largest Q2 2026 buy was Vanguard S&P 500 ETF: 12,295 shares worth $8.44M.
  • Prelude Capital Management added most to Janus Henderson in Q2 2026, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $25.1M.
  • Prelude Capital Management fully exited Clearwater Analytics in Q2 2026, selling an estimated $14.7M.
  • Prelude Capital Management's ten largest holdings make up 11% of its $1.37B portfolio in Q2 2026.
  • Prelude Capital Management opened 447 new positions and closed 410 in Q2 2026.
  • Prelude Capital Management's portfolio value rose 4.7% quarter-over-quarter to $1.37B.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.